Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Total Liabilities: 2021-2022

Historic Total Liabilities for Cardiol Therapeutics (CRDL) over the last 1 years, with Sep 2022 value amounting to $52.4 million.

  • Cardiol Therapeutics' Total Liabilities was N/A to $52.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $197.5 million, marking a year-over-year change of. This contributed to the annual value of $9.3 million for FY2021, which is N/A change from last year.
  • Per Cardiol Therapeutics' latest filing, its Total Liabilities stood at $52.4 million for Q3 2022, which was up 1,393.22% from -$4.1 million recorded in Q2 2022.
  • In the past 5 years, Cardiol Therapeutics' Total Liabilities registered a high of $79.4 million during Q1 2022, and its lowest value of -$4.1 million during Q2 2022.
  • Over the past 2 years, Cardiol Therapeutics' median Total Liabilities value was $52.4 million (recorded in 2022), while the average stood at $40.0 million.
  • Data for Cardiol Therapeutics' Total Liabilities shows a maximum YoY slumped of 265.39% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Cardiol Therapeutics' Total Liabilities stood at $69.7 million in 2021, then slumped by 265.39% to $52.4 million in 2022.
  • Its Total Liabilities stands at $52.4 million for Q3 2022, versus -$4.1 million for Q2 2022 and $79.4 million for Q1 2022.